IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback